Relugolix-d6
Product Specifications
Bioactivity
Relugolix-d6 is a deuterated compound of Relugolix. Relugolix has a CAS number of 737789-87-6. Relugolix is an orally available, non-peptide gonadotropin-releasing hormone (GnRH or luteinizing hormone-releasing hormone (LHRH) ) antagonist, with potential antineoplastic activity. Relugolix competitively binds to and blocks the GnRH receptor in the anterior pituitary gland, which both prevents GnRH binding to the GnRH receptor and inhibits the secretion and release of both luteinizing hormone (LH) and follicle stimulating hormone (FSH) . In males, the inhibition of LH secretion prevents the release of testosterone from Leydig cells in the testes. Since testosterone is required to sustain prostate growth, reducing testosterone levels may inhibit hormone-dependent prostate cancer cell proliferation.
Smiles
C1C(F)=C(CN2C(N(C3N=NC(OC)=CC=3)C(=O)C3C(CN(C([2H])([2H])[2H])C([2H])([2H])[2H])=C(SC=32)C2=CC=C(NC(NOC)=O)C=C2)=O)C(F)=CC=1
Molecular Formula
C29H21D6F2N7O5S
Molecular Weight
629.67
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
B2553-63C-HRP 200 µL
BMPR1B, NT (D17) (Bone Morphogenetic Protein Receptor Type-1B, BMP Type-1B Receptor, BMPR-1B, CDw293) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details 